Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ET0111 / Etern Biopharma
FLIGHT, NCT05522309: FGFR Inhibitor ET0111 Monotherapy in Patients With Advanced Solid Tumors	Recruiting	1	37	RoW	ET0111	Etern BioPharma (Shanghai) Co., Ltd	Advanced Solid Tumor	12/24	05/25